SG Americas Securities’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,789
Closed -$25K 3485
2025
Q4
$25K Buy
+14,789
New +$25.6K ﹤0.01% 3441
2025
Q3
Sell
-13,522
Closed -$12K 3481
2025
Q2
$12K Sell
13,522
-49,637
-79% -$29.4K ﹤0.01% 2852
2025
Q1
$29K Sell
63,159
-5,814
-8% -$3.41K ﹤0.01% 3341
2024
Q4
$35K Buy
68,973
+18,053
+35% +$13.3K ﹤0.01% 2966
2024
Q3
$46K Buy
+50,920
New +$47.2K ﹤0.01% 3260
2024
Q1
Sell
-30,889
Closed -$34K 3220
2023
Q4
$34K Buy
30,889
+11,779
+62% +$12.9K ﹤0.01% 2977
2023
Q3
$23K Buy
+19,110
New +$26K ﹤0.01% 3035
2022
Q2
Sell
-12,935
Closed -$20K 3511
2022
Q1
$20K Sell
12,935
-18,607
-59% -$28.9K ﹤0.01% 2884
2021
Q4
$77K Sell
31,542
-44,238
-58% -$104K ﹤0.01% 3133
2021
Q3
$191K Buy
+75,780
New +$194K ﹤0.01% 3263
2021
Q1
Sell
-13,053
Closed -$23K 3418
2020
Q4
$23K Buy
+13,053
New +$18.3K ﹤0.01% 3198
2020
Q2
Sell
-72,784
Closed -$60K 3783
2020
Q1
$60K Buy
72,784
+50,733
+230% +$50.5K ﹤0.01% 3144
2019
Q4
$20K Buy
+22,051
New +$18.4K ﹤0.01% 3146
2019
Q2
Sell
-14,574
Closed -$19K 3278
2019
Q1
$19K Buy
+14,574
New +$18.1K ﹤0.01% 3271
2018
Q2
Sell
-11,555
Closed -$27K 3457
2018
Q1
$27K Sell
11,555
-59,655
-84% -$140K ﹤0.01% 3136
2017
Q4
$134K Buy
71,210
+57,036
+402% +$125K ﹤0.01% 2697
2017
Q3
$35K Buy
+14,174
New +$35.1K ﹤0.01% 3366
2016
Q2
Sell
-13,179
Closed -$33K 2825
2016
Q1
$33K Buy
+13,179
New +$29.4K ﹤0.01% 2798

Other funds holding LCTX